FDA NDC Directory · JSON-LD · Markdown

EBGLYSS

NDC 0002-7772 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namelebrikizumab-lbkz
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA761306
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsLEBRIKIZUMAB (250 mg/2mL)
Marketing started20240913
Package count2

External sources

Source: openFDA. Public-domain (CC0).